CG Oncology (CGON) Total Current Liabilities (2023 - 2026)

CG Oncology's Total Current Liabilities history runs 4 years deep, the most recent figure standing at $35.2 million for Q1 2026.

• Quarterly Total Current Liabilities rose 55.53% year-over-year to $35.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.2 million (up 55.53% YoY) and the FY2025 annual result came in at $30.8 million, up 44.31% from the prior year.
• Total Current Liabilities was $35.2 million for Q1 2026 at CG Oncology, up from $30.8 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $35.2 million in Q1 2026 and bottomed at $10.0 million in Q1 2024.
• A 4-year average of $22.3 million and a median of $22.0 million in 2024 frame the typical range for Total Current Liabilities.
• Peak annual rise in Total Current Liabilities reached 156.31% in 2025, while the deepest fall reached 44.31% in 2025.
• CG Oncology's Total Current Liabilities stood at $14.3 million in 2023, then surged by 49.91% to $21.4 million in 2024, then jumped by 44.31% to $30.8 million in 2025, then rose by 14.2% to $35.2 million in 2026.
• Business Quant data shows CGON's Total Current Liabilities at $35.2 million in Q1 2026, $30.8 million in Q4 2025, and $30.5 million in Q3 2025.